The Compassionate Use Advisory Committee (CompAC) for development of pre-approval access to investigational drugs.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e18001
Abstract: e18001Background: In May 2015, CompAC was formed at NYU to provide guidance fairly and transparently on allocating a limited supply of , Daratumumab, to patients outside of clinical trials. Janssen... read more here.
Keywords: advisory committee; compac; compassionate use; compac development ... See more keywords